Phase 2a ID93 + GLA-SE Vaccine Trial in TB Patients After Treatment Completion
Clinical trial NCT02465216 · COMPLETED
Trial details
- NCT number
- NCT02465216
- Sponsor
- Access to Advanced Health Institute (AAHI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2017-01-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.